26 May 2013
Keywords: early, use, merck, co, aggrastat, benefits, stemi
Article | 08 September 2008
Early, in-ambulance treatment with antiplatelet agent, US drug major Merck & Co's Aggrastat (tirofiban HCl), in addition to the standard
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 September 2008
24 May 2013
© 2013 thepharmaletter.com